Solid Tumors: Asia Pacific Clinical Trial Landscape

According to GLOBOCAN, there were over 8.2 million new cases and over 5 million deaths due to solid cancers in Asia, with the region accounting for half of the new cancer cases and 60% of the world's deaths in 2020.

The selected locations of the Asia Pacific region (which include China, India, South Korea, Japan, Australia, New Zealand, Malaysia, Singapore, Thailand and the Philippines), emerged as a hub to an overwhelming cancer population, accounting for over 50%, 45%, 35% and 65% of the global incidence of lung, colorectal, breast and stomach cancers respectively, in 2020. In this region, breast, lung, colorectal and stomach cancers also showed the highest age-standardized incidence rates (ASIR) of 38, 25, 19 and 16 per 100,000 population respectively, in 2020. Lung, colorectal and stomach cancers were also the three top cancer indications where the ASIR even exceeded or was similar to that of the world incidence.